These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37004235)

  • 1. Risk Factors and Cardiovascular Events in Orthotopic Liver Transplantation.
    Ali A; Mitchell B; Donovan R; Patel SS; Danyi P; Giles H; Kang L; Fuchs M; Heuman D; Jovin IS
    J Gastrointestin Liver Dis; 2023 Mar; 32(1):51-57. PubMed ID: 37004235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MELD-XI Score and Coronary Artery Disease Prevalence and Extent Among In-Hospital Patients With End-Stage Liver Failure Awaiting Transplant.
    Keskin S; Çiftci O; Moray G; Müderrisoğlu H; Haberal M
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):88-92. PubMed ID: 32008505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Interventions before Liver Transplantation Might Not Avert Postoperative Cardiovascular Events.
    Snipelisky DF; McRee C; Seeger K; Levy M; Shapiro BP
    Tex Heart Inst J; 2015 Oct; 42(5):438-42. PubMed ID: 26504436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.
    D'Avola D; Cuervas-Mons V; Martí J; Ortiz de Urbina J; Lladó L; Jimenez C; Otero E; Suarez F; Rodrigo JM; Gómez MA; Fraga E; Lopez P; Serrano MT; Rios A; Fábrega E; Herrero JI
    Liver Transpl; 2017 Apr; 23(4):498-509. PubMed ID: 28160394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictors of post-transplant coronary events among liver transplant recipients.
    Malik MU; Russell SD; Pustavoitau A; Chacko M; Cosar AM; Thompson CB; Trilianos P; Dagher NN; Cameron AM; Gurakar A
    Hepatol Int; 2016 Nov; 10(6):974-982. PubMed ID: 27311889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning Models to Predict Major Adverse Cardiovascular Events After Orthotopic Liver Transplantation: A Cohort Study.
    Jain V; Bansal A; Radakovich N; Sharma V; Khan MZ; Harris K; Bachour S; Kleb C; Cywinski J; Argalious M; Quintini C; Menon KVN; Nair R; Tong M; Kapadia S; Fares M
    J Cardiothorac Vasc Anesth; 2021 Jul; 35(7):2063-2069. PubMed ID: 33750661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-Operative Cardiovascular Testing before Liver Transplantation.
    Case BC; Yang M; Qamer SZ; Kumar S; Yerasi C; Forrestal BJ; Chezar-Azerrad C; Medranda GA; Bernardo NL; Rogers T; Satler LF; Hashim H; Satoskar RS; Lalos AT; Waksman R; Ben-Dor I
    Am J Cardiol; 2021 Aug; 152():132-137. PubMed ID: 34103158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pre-Transplant Profile of Cardiovascular Risk Factors and Its Impact on Long-Term Mortality After Liver Transplantation.
    Główczyńska R; Galas M; Witkowska A; Ołdakowska-Jedynak U; Raszeja-Wyszomirska J; Krasuski K; Milkiewicz P; Krawczyk M; Zieniewicz K; Opolski G
    Ann Transplant; 2018 Aug; 23():591-597. PubMed ID: 30127335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Satapathy SK; Vanatta JM; Helmick RA; Flowers A; Kedia SK; Jiang Y; Ali B; Eason J; Nair SP; Ibebuogu UN
    Transplantation; 2017 Apr; 101(4):793-803. PubMed ID: 28099403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of transradial cardiac catheterization in patients with end-stage liver disease.
    Jacobs E; Singh V; Damluji A; Shah NR; Warsch JL; Ghanta R; Martin P; Alfonso CE; Martinez CA; Moscucci M; Cohen MG
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):360-6. PubMed ID: 23723127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between coronary artery disease and cardiovascular events early after liver transplantation.
    Patel SS; Lin FP; Rodriguez VA; Bhati C; John BV; Pence T; Siddiqui MB; Sima AP; Abbate A; Reichman T; Siddiqui MS
    Liver Int; 2019 Jul; 39(7):1363-1371. PubMed ID: 30848862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Coronary Angiography in Pre-Liver Transplantation Cardiac Evaluation: Experience From an Asian Transplant Institution.
    Pang NQ; Kow WCA; Law JH; Pan LTT; Lim BLK; Wong CCR; Chang KYS; Ganpathi IS; Madhavan K
    Transplant Proc; 2017 Oct; 49(8):1797-1805. PubMed ID: 28923628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Coronary Artery Disease and Statins on Survival After Liver Transplantation.
    Patel SS; Rodriguez VA; Siddiqui MB; Faridnia M; Lin FP; Chandrakumaran A; Laurenzano J; Clinton J; Kowlgi GN; Kirkman D; Sima AP; Liptrap E; Bhati C; Siddiqui MS
    Liver Transpl; 2019 Oct; 25(10):1514-1523. PubMed ID: 31344758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive review of coronary artery disease in patients with end-stage liver disease.
    Dangl M; Eisenberg T; Grant JK; Vincent L; Colombo R; Sancassani R; Braghiroli J; Martin P; Vianna R; Nicolau-Raducu R; Mendoza C
    Transplant Rev (Orlando); 2022 Jul; 36(3):100709. PubMed ID: 35665672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years.
    Koshy AN; Gow PJ; Han HC; Teh AW; Jones R; Testro A; Lim HS; McCaughan G; Jeffrey GP; Crawford M; Macdonald G; Fawcett J; Wigg A; Chen JWC; Gane EJ; Munn SR; Clark DJ; Yudi MB; Farouque O
    Eur Heart J Qual Care Clin Outcomes; 2020 Oct; 6(4):243-253. PubMed ID: 32011663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Liver Graft Recipient Workup in Predicting of Early Cardiovascular Events During Liver Transplantation: A Single-Center Experience.
    Raszeja-Wyszomirska J; Glowczynska R; Kostrzewa K; Janik M; Zygmunt M; Zborowska H; Krawczyk M; Niewinski G; Galas M; Krawczyk M; Zieniewicz K; Milkiewicz P; Opolski G
    Transplant Proc; 2018 Sep; 50(7):1997-2001. PubMed ID: 30177096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pre-operative coronary artery disease on cardiovascular events following lung transplantation.
    Chaikriangkrai K; Jyothula S; Jhun HY; Estep J; Loebe M; Scheinin S; Torre-Amione G
    J Heart Lung Transplant; 2016 Jan; 35(1):115-121. PubMed ID: 26452997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Liver Transplantation in Patients With Preexisting Coronary Artery Disease.
    Reznicek E; Sasaki K; Montane B; Sims A; Beard J; Fares M; Sharma V; Cywinski J; Quintini C; Aucejo FN; Eghtesad B; Miller CM; Menon KVN
    Transplantation; 2023 Apr; 107(4):933-940. PubMed ID: 36397734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markedly prolonged QTc interval in end-stage liver disease and risk of 30-day cardiovascular event after liver transplant.
    Kim KS; Kwon HM; Jung KW; Sang BH; Moon YJ; Kim B; Jun IG; Song JG; Hwang GS
    J Gastroenterol Hepatol; 2021 Mar; 36(3):758-766. PubMed ID: 32804412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.